一氧化氮对术前内皮功能障碍患者长时间体外循环后急性肾损伤的影响:随机临床试验
该双盲、单中心、安慰剂对照随机试验纳入250例术前存在内皮功能障碍且体外循环超过90分钟的成人心脏手术患者,比较围术期吸入80 ppm一氧化氮24小时与安慰剂对术后急性肾损伤(AKI)的影响。结果显示一氧化氮组AKI发生率为44.0%,对照组为43.2%(校正OR 1.00,95%CI 0.59-1.69),差异无统计学意义,不支持该人群常规使用一氧化氮。
要点
- 术前内皮功能障碍患者长时间体外循环后AKI发生率高,但吸入一氧化氮未能降低其发生率。
- 一氧化氮组与对照组AKI发生率分别为44.0%和43.2%,校正OR 1.00(95%CI 0.59-1.69)。
- AKI分期及住院期间和随访至1年的肾脏替代治疗需求在两组间也无显著差异。
核心结论
- 在术前存在内皮功能障碍并接受长时间体外循环的心脏手术患者中,围术期给予80 ppm一氧化氮24小时未显著降低术后急性肾损伤发生率。
- 研究结果不支持在该患者人群中常规使用一氧化氮。
研究设计与样本
- 双盲、单中心、安慰剂对照随机临床试验,纳入250例术前存在内皮功能障碍且体外循环持续时间超过90分钟的成人心脏手术患者。
- 患者随机分为一氧化氮组(体外循环期间经氧合器给予80 ppm,术后经呼吸机和面罩继续给药,共24小时)和安慰剂组(氮氧混合气体),每组125例。
- 主要结局为基于KDIGO标准定义的术后急性肾损伤发生率;次要结局包括AKI严重程度及住院期间、6周、90天和1年时肾脏替代治疗需求。
主要发现
- 一氧化氮组55例(44.0%)发生AKI,对照组54例(43.2%)发生AKI,校正OR为1.00(95%CI 0.59-1.69)。
- 次要结局包括1期、2期或3期AKI及所有时间点的肾脏替代治疗需求在两组间相似。
关键数值与推荐
- AKI定义采用KDIGO标准。
- 一氧化氮给药剂量为80 ppm,经氧合器于体外循环期间给予,术后经呼吸机和面罩继续给药,总时长24小时。
临床怎么用
- 对于术前存在内皮功能障碍并接受长时间体外循环的心脏手术患者,围术期吸入80 ppm一氧化氮24小时不应作为常规策略用于降低术后AKI风险。
局限性
- 原文摘要未报告局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prolonged cardiopulmonary bypass (CPB) causes hemolysis, reducing nitric oxide availability and increasing the risk of acute kidney injury (AKI) after cardiac surgery. While previous studies suggest inhaled nitric oxide may reduce AKI in certain populations, its effect in patients with preexisting endothelial dysfunction, a condition marked by impaired nitric oxide production, is unknown. This trial investigates whether perioperative nitric oxide administration reduces AKI in patients with preexisting endothelial dysfunction undergoing prolonged CPB. METHODS: The authors conducted a double-blind, single-center, placebo-controlled, randomized clinical trial involved 250 adult cardiac surgery patients with preexisting endothelial dysfunction undergoing CPB lasting more than 90 min. Participants were randomized to either receive nitric oxide at 80 ppm via the oxygenator during CPB, continuing postoperatively via ventilator and facemask, or a placebo of nitrogen-oxygen gas mixture for 24 h. The primary outcome was the incidence of postoperative AKI, defined by Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Secondary outcomes included AKI severity and the need for renal replacement therapy during hospitalization and at 6 weeks, 90 days, and 1 yr. RESULTS: Of the 250 patients (median age, 66 yr; interquartile range, 59, 73 yr; 56 [22.4%] women), 125 were assigned to each group. AKI occurred in 55 (44.0%) patients in the nitric oxide group and 54 (43.2%) patients in the control group (adjusted odds ratio, 1.00; 95% CI, 0.59 to 1.69). Secondary outcomes, including stage 1, 2, or 3 AKI and renal replacement therapy at all timepoints, were also similar between groups. CONCLUSIONS: In cardiac surgery patients with preexisting endothelial dysfunction undergoing prolonged CPB, perioperative administration of 80 ppm nitric oxide for 24 h did not significantly reduce postoperative AKI. These findings do not support the routine use of nitric oxide in this patient population.
引用
- Arora P, Di Fenza R, Shetty NS, et al. Nitric Oxide to Reduce Acute Kidney Injury in Patients with Preexisting Endothelial Dysfunction Requiring Prolonged Cardiopulmonary Bypass: A Randomized Clinical Trial. Anesthesiology. 2025. PMID: 41270263. doi:10.1097/ALN.0000000000005861
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。